> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Info Collection Extension for Drug GMPs
- URL: https://www.fdaweb.com/info-collection-extension-for-drug-gmps/
- Published: 2021-06-09T12:00:00.000Z
- Updated: 2026-09-14T17:02:31.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5149493

*Federal Register* notice: FDA has submitted to OMB an information collection extension entitled “Current Good Manufacturing Practice for Finished Pharmaceuticals, Including Medical Gases, and Active Pharmaceutical Ingredients — 21 CFR Parts 210 and 211 and 21 U.S.C 351(a)(2)(B)” (OMB Control Number 0910-0139). The collection supports FDA regulations that govern the manufacture, processing, packing, or holding of finished pharmaceuticals, including medical gases and active pharmaceutical ingredients. FDA says its regulations enable a common understanding of the regulatory process by describing requirements to be followed by drug manufacturers, applicants, and the agency. To view the notice, click [here](https://public-inspection.federalregister.gov/2021-12214.pdf?ref=fdaweb.com).